The jury highlighted the deal’s transformative impact: together with ECG’s vet-led team, we helped build a pioneering equine veterinary platform, and the partnership with CNP supports long-term international growth while protecting ECG’s clinician-first model.
They also praised the innovative structure for balancing ethical considerations with aligned outcomes for investors and management, showing how purpose and performance can coexist through clear vision, strong execution, and lasting value creation.
